Nanopharmacology is defined as application of Nanotechnology for the development and/or discovery of methods to deliver drugs and nanomedicines developed to operate on a nanometer size range (typically <500 nm) with novel engineered properties that provide medical and 4pharmaceutical benefits, specifically for treatment of diseases, such drug delivery system is the nanoparticle drug delivery system (NPDDS). Below 100 nm, materials exhibit different, more desirable physical, chemical, and biological properties. Given the enormity and immediacy of the unmet needs of therapeutic areas which can lead to drugs that can extend life and 5save untimely deaths. Challenges in pharmaceutical industry are poor aqueous solubility, tunable release profiles, structural stability, biocompatibility, and the confinement of therapeutic action of drugs to diseased sites. NPDDS has improved pharmacokinetics of drugs like solubility due to the increased surface-to-volume ratio of small particles and increased bioavailability due to protection against decrease in drug effects due to excessive metabolism.
Research Article: Clinical Pharmacology and Toxicology Research
Research Article: Clinical Pharmacology and Toxicology Research
Posters & Accepted Abstracts: Journal of Pharmacology and Medicinal Chemistry
Posters & Accepted Abstracts: Journal of Pharmacology and Medicinal Chemistry
Posters & Accepted Abstracts: Journal of Pharmacology and Medicinal Chemistry
Posters & Accepted Abstracts: Journal of Pharmacology and Medicinal Chemistry
ScientificTracks Abstracts: Journal of Pharmacology and Medicinal Chemistry
ScientificTracks Abstracts: Journal of Pharmacology and Medicinal Chemistry
ScientificTracks Abstracts: Journal of Pharmacology and Medicinal Chemistry
ScientificTracks Abstracts: Journal of Pharmacology and Medicinal Chemistry